BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Digital Artificial Intelligence

Hoth Therapeutics' Merveille.ai Achieves Breakthrough in Obesity Treatment with AI-Driven Therapeutic Candidate

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biopharmaceutical company, is excited to announce a significant breakthrough by its sub...

March 28, 2024 | News

Clarivate Acquires Silicon Valley's MotionHall to Boost AI-Driven Life Sciences & Healthcare Solutions

Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, has announced an agreement to acquire the substantial ma...

March 22, 2024 | News

Cognizant and NVIDIA Accelerate Drug Discovery with Generative AI

Cognizant (NASDAQ: CTSH) is advancing the application of generative AI (gen AI) technology with the NVIDIA BioNeMo platform to solve complex chal...

March 20, 2024 | News

BioGeometry and Sanyou Bio Announce Pioneering Alliance to Accelerate AI-Powered Antibody Research

BioGeometry, a frontrunner in digital biology and AI-driven protein design, alongside Sanyou Bio, a leading force in the high-tech biotechnology sector, ha...

March 19, 2024 | News

South Korean Lunit Forges Ahead in Europe with AI-Enhanced Cancer Detection

Lunit, a trailblazer in AI-driven diagnostics and cancer treatment, announced significant strides in its European market presence through new...

March 19, 2024 | News

EDAN and GH Labs Collaborate to Develop AI-Enabled Ultrasound Devices

Under the agreement signed on March 13, 2024, in Bellevue, Washington, EDAN and GH Labs will combine their expertise to create innovative ul...

March 18, 2024 | News

Lunit's Bid to Acquire Volpara Gains Momentum with New Zealand High Court's Initial Nod

Volpara Health Technologies (Volpara; ASX:VHT), renowned for its AI-driven solutions in cancer diagnostics, is on the brink of a transformative merger with...

March 14, 2024 | News

Novel Molecules From Generative AI to Phase II: Pioneering TNIK Inhibitors for Fibrotic Diseases

In a groundbreaking study published in Nature Biotechnology, Insilico Medicine, along with its collaborators, showcases the journey of INS018_055 f...

March 13, 2024 | News

CAIR Launches Revolutionary CARES Copilot 1.0, Elevating AI in Healthcare

The Centre for Artificial Intelligence and Robotics (CAIR), under the Hong Kong Institute of Science & Innovation, Chinese Acad...

March 12, 2024 | News

QIAGEN Advances Drug Discovery with AI-Driven Biomedical Knowledge Base Featuring 640 Million Relationships

QIAGEN Biomedical KB-AI contains over 640 million biomedical relationships, including gene, disease and drug causal relationships, to aid in data-dr...

March 04, 2024 | News

VinBrain and Global Fund Partner to Fight Tuberculosis in Vietnam with AI in 2024

VinBrain is the sole entity chosen for this agreement with Global Fund in 2024. DrAid™ for TB Screening, a solution developed from VinBrain's in...

February 29, 2024 | News

Ono Pharmaceutical Partners with InveniAI to Revolutionize Drug Discovery Using AI

Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") has announced a strategic partnership with the AI-driven company InveniAI...

February 22, 2024 | News

GSK Secures License for Elsie Biotechnologies' Cutting-Edge Discovery Platform

Kevin Green, Chief Operating Officer of Elsie Biotechnologies, expressed enthusiasm, stating, "We are pleased that GSK ha...

February 15, 2024 | News

VantAI and Bristol Myers Squibb Forge AI-Driven Partnership to Propel Molecular Glue Drug Discovery

VantAI, a trailblazer in artificial intelligence (AI)-enabled drug discovery, has announced a groundbreaking collaboration with pharmaceutical giant Bristo...

February 14, 2024 | News

Stay Connected